# ExoCoBio acquires majority ownership of BENEV

ExoCoBio, a leader in exosomes technology, has completed the acquisition of majority ownership of BENEV, a US FDA-registered manufacturer of pharmaceutical, cosmeceutical, and medical devices.

- Type: Acquisition
- Announced: 2023-08-09
- Where: United States
- Status: completed
- Products: exosomes technology, Sylfirm X, Miracu PDO threads, BENEV Exosomes
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ExoCoBio](https://endata.com/companies/71943.md) (acquirer)
- [BENEV](https://endata.com/companies/71944.md) (target)

## Sources

- [benev.com](https://www.benev.com/post/meet-exocobio-our-strategic-partner-in-advancing-exosomes-technology), 2023-08-09: "We are very pleased with this important acquisition, which will contribute to the fast growth and business expansion of ExoCoBio."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.